Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations

Blood (2013) 121 (2): 385–391.

https://doi.org/10.1182/blood-2012-07-442772

Published: 2013

Includes: Supplemental data

Journal Articles

Cytogenetic, Molecular and Clinical Features Associated with Rare CBFB-MYH11 Fusion Transcripts in Patients (Pts) with Acute Myeloid Leukemia (AML) and inv(16)/t(16;16)

Colin G Edwards, PhD, Kati Maharry, MAS, Krzysztof Mrózek, MD, PhD, Sebastian Schwind, MD, Peter Paschka, MD, Deedra Nicolet, MS, Jessica Kohlschmidt, PhD, Thomas W Prior, PhD, Yue-Zhong Wu, MS, Jonathan E. Kolitz, MD, William Blum, MD, Mark J. Pettenati, PhD, Paola Dal Cin, PhD, Andrew J. Carroll, PhD, Michael A Caligiuri, MD, Richard A. Larson, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD

Blood (2011) 118 (21): 2514.

https://doi.org/10.1182/blood.V118.21.2514.2514

Published: 2011

Journal Articles

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

Blood (2011) 118 (21): 414.

https://doi.org/10.1182/blood.V118.21.414.414

Published: 2011

Journal Articles

A Single Institution Analysis of Incidence of Recurrent Chromosomal Abnormalities in Adult ALL Patients According to Race, Gender, and Age

Victoria Chiou, MD, Jacob Tiegs, MD, Scott Isom, MS, Mark J. Pettenati, PhD, Susan Lyerly, PA, Leslie R. Ellis, MD, Timothy Pardee, MD, PhD, Berenzon Dmitriy, MD, Bayard L. Powell, MD, Denise A Levitan, MD

Blood (2011) 118 (21): 4869.

https://doi.org/10.1182/blood.V118.21.4869.4869

Published: 2011

Journal Articles

Prognostic Significance of Unbalanced Chromosome Abnormalities Used by 2008 World Health Organization (WHO) Classification to Define “Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes” in Adults: a Cancer and Leukemia Group B (CALGB) Study.

Krzysztof Mrózek, MD, PhD, Kelsi B. Holland, MS, Mark J. Pettenati, PhD, Kati Maharry, MAS, Guido Marcucci, MD, Maria R. Baer, MD, Jonathan E. Kolitz, MD, Dean Margeson, MAS, Colin G. Edwards, PhD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Clara D. Bloomfield, MD

Blood (2009) 114 (22): 2602.

https://doi.org/10.1182/blood.V114.22.2602.2602

Published: 2009

Journal Articles

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201

Allen R. Chauvenet, Paul L. Martin, Meenakshi Devidas, Stephen B. Linda, Beverly A. Bell, Joanne Kurtzberg, Jeanette Pullen, Mark J. Pettenati, Andrew J. Carroll, Jonathan J. Shuster, Bruce Camitta

Blood (2007) 110 (4): 1105–1111.

https://doi.org/10.1182/blood-2006-12-061689

Published: 2007

Includes: Supplemental data

Journal Articles

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek, Amy S. Ruppert, Andrew J. Carroll, James W. Vardiman, Mark J. Pettenati, Maria R. Baer, Mazin B. Qumsiyeh, Prasad R. Koduru, Yi Ning, Robert J. Mayer, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield

Blood (2006) 108 (1): 63–73.

https://doi.org/10.1182/blood-2005-11-4354

Published: 2006

Journal Articles

Pre-Treatment Cytogenetics Predict Complete Remission and Long-Term Outcome in Patients (Pts) ≥60 Years with Acute Myeloid Leukemia (AML): Results from Cancer and Leukemia Group B (CALGB) 8461.

Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek, James W. Vardiman, Andrew J. Carroll, Mark J. Pettenati, Bayard L. Powell, Joseph O. Moore, Jonathan E. Kolitz, Maria R. Baer, Sandra H. Bigner, Prasad R. Koduru, Judith Stamberg, Robert J. Mayer, Richard M. Stone, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield

Blood (2004) 104 (11): 568.

https://doi.org/10.1182/blood.V104.11.568.568

Published: 2004

Journal Articles

Central Review of Cytogenetics Is Essential for Cooperative Group Clinical and Correlative Studies of Acute Leukemia: The Cancer and Leukemia Group B (CALGB) 8461 Experience.

Krzysztof Mrózek, Andrew J. Carroll, Kati Maharry, Kathleen W. Rao, Shivanand R. Patil, Mark J. Pettenati, Michael S. Watson, Diane C. Arthur, Ramana Tantravahi, Nyla A. Heerema, Prasad R.K. Koduru, Sandra H. Bigner, Judith Stamberg, AnneMarie W. Block, Colin G. Edwards, Lisa J. Sterling, Clara D. Bloomfield

Blood (2004) 104 (11): 1081.

https://doi.org/10.1182/blood.V104.11.1081.1081

Published: 2004

Journal Articles

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461): Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form. 59

John C. Byrd, Krzysztof Mrózek, Richard K. Dodge, Andrew J. Carroll, Colin G. Edwards, Diane C. Arthur, Mark J. Pettenati, Shivanand R. Patil, Kathleen W. Rao, Michael S. Watson, Prasad R. K. Koduru, Joseph O. Moore, Richard M. Stone, Robert J. Mayer, Eric J. Feldman, Frederick R. Davey, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield

Blood (2002) 100 (13): 4325–4336.

https://doi.org/10.1182/blood-2002-03-0772

Published: 2002

Journal Articles

Detection of Abnormal Pretransplant Clones in Progenitor Cells of Patients Who Developed Myelodysplasia After Autologous Transplantation

Elisabetta Abruzzese, James E. Radford, Jeffrey S. Miller, James J. Vredenburgh, P. Nagesh Rao, Mark J. Pettenati, Julia M. Cruz, James J. Perry, Sergio Amadori, David D. Hurd

Blood (1999) 94 (5): 1814–1819.

https://doi.org/10.1182/blood.V94.5.1814

Published: 1999

Journal Articles

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

Meir Wetzler, Richard K. Dodge, Krzysztof Mrózek, Andrew J. Carroll, Ramana Tantravahi, AnneMarie W. Block, Mark J. Pettenati, Michelle M. Le Beau, Stanley R. Frankel, Carleton C. Stewart, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield

Blood (1999) 93 (11): 3983–3993.

https://doi.org/10.1182/blood.V93.11.3983

Published: 1999

NARROW

inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations

Cytogenetic, Molecular and Clinical Features Associated with Rare CBFB-MYH11 Fusion Transcripts in Patients (Pts) with Acute Myeloid Leukemia (AML) and inv(16)/t(16;16)

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

A Single Institution Analysis of Incidence of Recurrent Chromosomal Abnormalities in Adult ALL Patients According to Race, Gender, and Age

Prognostic Significance of Unbalanced Chromosome Abnormalities Used by 2008 World Health Organization (WHO) Classification to Define “Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes” in Adults: a Cancer and Leukemia Group B (CALGB) Study.

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

Pre-Treatment Cytogenetics Predict Complete Remission and Long-Term Outcome in Patients (Pts) ≥60 Years with Acute Myeloid Leukemia (AML): Results from Cancer and Leukemia Group B (CALGB) 8461.

Central Review of Cytogenetics Is Essential for Cooperative Group Clinical and Correlative Studies of Acute Leukemia: The Cancer and Leukemia Group B (CALGB) 8461 Experience.

Detection of Abnormal Pretransplant Clones in Progenitor Cells of Patients Who Developed Myelodysplasia After Autologous Transplantation

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only